Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acceptability, Optimization and Cost-effectiveness for Self-sampling Cervical Cancer Screening.

NCT05314907 is registered in ClinicalTrials.gov with Institut d'Investigació Biomèdica de Bellvitge as lead sponsor.

NCT NCT05314907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05314907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acceptability, Optimization and Cost-effectiveness for Self-sampling Cervical Cancer Screening.
Lead sponsor
Institut d'Investigació Biomèdica de Bellvitge
Phase
Not applicable
Overall status
Unknown status
Start date
November 28, 2018
Completion date
June 30, 2022
Enrollment
1,614 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer screening, hpv-related cervical carcinoma, self-sampling